Farquhar C, Vandekerckhove P, Lilford R
Obstetrics & Gynaecology, National Women's Hospital, Claude Rd, Epsom, Auckland, New Zealand, 1003.
Cochrane Database Syst Rev. 2001(4):CD001122. doi: 10.1002/14651858.CD001122.
Problems in inducing ovulation in women with polycystic ovary syndrome (PCOS) and anovulation (failure to ovulate) are well recognised. Surgical ovarian wedge resection was the first established treatment for anovulatory PCOS patients but was largely abandoned because of the risk of post-surgical adhesion formation. It was replaced by medical ovulation induction with clomiphene and gonadotrophins. However patients with PCOS treated with gonadotrophins often have a polyfollicular response and are exposed to the risks of ovarian hyperstimulation syndrome (OHSS) and multiple pregnancy. Although effective, it is an expensive, stressful and time consuming form of treatment requiring intensive monitoring. A new surgical therapy, laparoscopic ovarian "drilling", may avoid or reduce the need, or facilitate the use, of gonadotrophins for inducing ovulation. The procedure can be done on an outpatient basis with less trauma and fewer postoperative adhesions. It has been claimed in many uncontrolled observational studies that it is followed, at least temporarily, by a high rate of spontaneous postoperative ovulation and conception, or that subsequent medical ovulation induction becomes easier.
To determine the effectiveness and safety of laparoscopic ovarian drilling with ovulation induction for subfertile women with clomiphene resistant polycystic ovarian syndrome.
The search strategy of the Menstrual Disorders and Subfertility Group was used for the identification of randomised controlled trials (RCTS). A computerised MEDLINE search was used to identify non randomised controlled trials.
Trials were eligible for inclusion if treatment consisted of laparoscopic ovarian drilling in order to induce ovulation in subfertile women with PCOS and compared with a concurrent control group.
Fifteen trials were identified; six were included in the review all of which were randomised. All trials were assessed for quality criteria. The main studied outcomes were ovulation and pregnancy rates. Miscarriage rate, multiple pregnancy rate, and incidence of overstimulation and ovarian hyperstimulation syndrome rate were secondary outcomes.
The ongoing pregnancy rate following ovarian drilling compared with gonadotrophins differed according to the length of follow up. Overall, the pooled OR (all studies) was not statistically significant (OR 1.27, 95% CI 0.77, 1.98). Multiple pregnancy rates were reduced in the ovarian drilling arms of the four trials where there was a direct comparison with gonadotrophins (OR 0.16, 95%CI 0.03,0.98). There was no difference in miscarriage rates in the drilling group when compared with gonadotrophin in these trials (OR 0.61, 955% 0.17, 2.16).
REVIEWER'S CONCLUSIONS: There is insufficient evidence of a difference in cumulative ongoing pregnancy rates between laparoscopic ovarian drilling after 6-12 months follow up and 3-6 cycles of ovulation induction with gonadotrophins as a primary treatment for subfertile patients with anovulation (failure to ovulate) and polycystic ovarian syndrome (PCOS). Multiple pregnancy rates are considerably reduced in those women who conceive following laparoscopic drilling.
多囊卵巢综合征(PCOS)女性诱导排卵以及无排卵(无法排卵)的问题已得到充分认识。手术卵巢楔形切除术是最早确立的针对无排卵PCOS患者的治疗方法,但由于术后粘连形成的风险,该方法在很大程度上已被弃用。它被克罗米芬和促性腺激素的药物促排卵治疗所取代。然而,接受促性腺激素治疗的PCOS患者通常会出现多卵泡反应,并面临卵巢过度刺激综合征(OHSS)和多胎妊娠的风险。虽然有效,但这是一种昂贵、有压力且耗时的治疗方式,需要密切监测。一种新的手术疗法,即腹腔镜卵巢“打孔”,可能避免或减少使用促性腺激素诱导排卵的需求,或便于其使用。该手术可在门诊进行,创伤较小,术后粘连较少。许多非对照观察性研究称,术后至少短期内会有较高的自发排卵和受孕率,或者后续的药物促排卵会变得更容易。
确定腹腔镜卵巢打孔联合促排卵治疗对克罗米芬抵抗的多囊卵巢综合征不育女性的有效性和安全性。
月经紊乱与不育组的检索策略用于识别随机对照试验(RCT)。使用计算机化的MEDLINE检索来识别非随机对照试验。
如果治疗包括腹腔镜卵巢打孔以诱导PCOS不育女性排卵,并与同期对照组进行比较,则试验符合纳入标准。
共识别出15项试验;6项被纳入综述,所有这些都是随机试验。所有试验均根据质量标准进行评估。主要研究结局为排卵率和妊娠率。流产率、多胎妊娠率以及过度刺激和卵巢过度刺激综合征的发生率为次要结局。
与促性腺激素相比,卵巢打孔后的持续妊娠率因随访时间长短而异。总体而言,汇总的OR(所有研究)无统计学意义(OR 1.27,95%CI 0.77,1.98)。在四项直接与促性腺激素比较的试验中,卵巢打孔组的多胎妊娠率降低(OR 0.16,95%CI 0.03,0.98)。在这些试验中,打孔组与促性腺激素组相比,流产率无差异(OR 0.61,95%CI 0.17,2.16)。
对于无排卵(无法排卵)和多囊卵巢综合征(PCOS)的不育患者,作为主要治疗方法,随访6 - 12个月后的腹腔镜卵巢打孔与3 - 6个周期的促性腺激素促排卵诱导治疗相比,累积持续妊娠率是否存在差异,证据不足。接受腹腔镜打孔后受孕的女性多胎妊娠率显著降低。